DENIS OLEARY, a director at $CRWD, sold 478 shares of the company on 12-05-2025 for an estimated $246,805. We received data on the trade from a recent SEC filing. This was a sale of approximately 4.2% of their shares of this class of stock. Following this trade, they now own 10,816 shares of this class of $CRWD stock.
$CRWD Insider Trading Activity
$CRWD insiders have traded $CRWD stock on the open market 195 times in the past 6 months. Of those trades, 0 have been purchases and 195 have been sales.
Here’s a breakdown of recent trading of $CRWD stock by insiders over the last 6 months:
- MICHAEL SENTONAS (PRESIDENT) has made 0 purchases and 10 sales selling 93,088 shares for an estimated $45,812,158.
- GEORGE KURTZ (PRESIDENT AND CEO) has made 0 purchases and 60 sales selling 84,597 shares for an estimated $40,062,997.
- ROXANNE S AUSTIN has made 0 purchases and 9 sales selling 45,000 shares for an estimated $22,165,000.
- BURT W. PODBERE (CHIEF FINANCIAL OFFICER) has made 0 purchases and 23 sales selling 35,260 shares for an estimated $16,826,188.
- SAMEER K GANDHI has made 0 purchases and 61 sales selling 28,750 shares for an estimated $13,956,328.
- DENIS OLEARY has made 0 purchases and 4 sales selling 7,750 shares for an estimated $3,994,628.
- ANURAG SAHA (CHIEF ACCOUNTING OFFICER) has made 0 purchases and 9 sales selling 7,991 shares for an estimated $3,876,185.
- JOHANNA FLOWER has made 0 purchases and 19 sales selling 4,420 shares for an estimated $2,135,374.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CRWD Hedge Fund Activity
We have seen 1,093 institutional investors add shares of $CRWD stock to their portfolio, and 857 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,626,924 shares (+70.5%) to their portfolio in Q3 2025, for an estimated $797,810,991
- MORGAN STANLEY removed 1,617,058 shares (-20.0%) from their portfolio in Q3 2025, for an estimated $792,972,902
- VESTOR CAPITAL, LLC removed 977,184 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $479,191,489
- PRICE T ROWE ASSOCIATES INC /MD/ added 958,014 shares (+29.4%) to their portfolio in Q3 2025, for an estimated $469,790,905
- PATHSTONE HOLDINGS, LLC removed 843,963 shares (-25.6%) from their portfolio in Q3 2025, for an estimated $413,862,575
- GOLDMAN SACHS GROUP INC removed 710,473 shares (-30.8%) from their portfolio in Q3 2025, for an estimated $348,401,749
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 630,875 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $309,368,482
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CRWD Revenue
$CRWD had revenues of $1.2B in Q3 2026. This is an increase of 22.18% from the same period in the prior year.
You can track CRWD financials on Quiver Quantitative's CRWD stock page.
$CRWD Congressional Stock Trading
Members of Congress have traded $CRWD stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CRWD stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 09/11.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/16 and 1 sale worth up to $15,000 on 08/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CRWD Analyst Ratings
Wall Street analysts have issued reports on $CRWD in the last several months. We have seen 22 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 12/04/2025
- JP Morgan issued a "Overweight" rating on 12/03/2025
- Rosenblatt issued a "Buy" rating on 12/03/2025
- BMO Capital issued a "Outperform" rating on 12/03/2025
- Wedbush issued a "Outperform" rating on 12/01/2025
- Keybanc issued a "Overweight" rating on 12/01/2025
- DA Davidson issued a "Buy" rating on 11/25/2025
To track analyst ratings and price targets for $CRWD, check out Quiver Quantitative's $CRWD forecast page.
$CRWD Price Targets
Multiple analysts have issued price targets for $CRWD recently. We have seen 37 analysts offer price targets for $CRWD in the last 6 months, with a median target of $570.0.
Here are some recent targets:
- Gabriela Borges from Goldman Sachs set a target price of $564.0 on 12/04/2025
- Fatima Boolani from Citigroup set a target price of $595.0 on 12/04/2025
- Shyam Patil from Susquehanna set a target price of $600.0 on 12/03/2025
- Roger Boyd from UBS set a target price of $590.0 on 12/03/2025
- Kingsley Crane from Canaccord Genuity set a target price of $515.0 on 12/03/2025
- Matthew Hedberg from RBC Capital set a target price of $621.0 on 12/03/2025
- Dan Ives from Wedbush set a target price of $600.0 on 12/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
